Hamster model offers clues for cracking long Covid; FDA advisers endorse Bluebird gene therapy for rare blood disorder

If they genuinely mimic long Covid in humans, the hamsters could allow researchers to explore the basic biology of the disease. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      Are these Cocoa Krispies-loving hamsters a key to cracking long Covid? By Jason Mast Adobe If they genuinely mimic long Covid in humans, the hamsters could allow researchers to explore the basic biology of the disease. Read More STAT+: FDA advisers endorse Bluebird gene therapy for rare blood disorder By Damian Garde Ruby Wallau for STAT The one-time treatment could be a cure for some patients with a rare blood disorder called beta-thalassemia. Read More STAT+: GSK says RSV vaccine for older adults 'offers exceptional protection' By Matthew Herper Imaginechina via AP The company said that it plans to submit the data to regulators, including the Food and Drug Administration, in the second half of the year. Read More Sponsor content by Takeda Oncology Progress that matters in cancer care Advancements in the oncology industry are redefining what it means to treat cancer. Each year, meetings like the annual American Society of Clinical Oncology (ASCO) conference provide a platform to discuss this progress. Read more from an industry expert on three important areas in cancer care that have the potential to transform patients' lives. STAT+: Florida hospital system sues religious sharing ministry over unpaid medical claims By Bob Herman Adobe Christian health sharing ministries are not true insurance providers. A Florida hospital system is taking one to court over unpaid claims. Read More Opinion: Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity By Thomas B. Cueni David Goldman/AP Given the abundance of Covid-19 vaccine doses, a proposal to waive intellectual property rights for making them is puzzling. Read More Opinion: Pursuit of profits is driving drug companies to break the 340B law By Maureen Testoni Adobe Seventeen drug companies are flouting the 340B law that helps safety-net and rural hospitals treat low-income and underserved patients. Read More Friday, June 10, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser